KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Debt: 2011-2021

Historic Total Debt for TherapeuticsMD (TXMD) over the last 6 years, with Dec 2021 value amounting to $188.3 million.

  • TherapeuticsMD's Total Debt fell 49.88% to $93.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $575.5 million, marking a year-over-year decrease of 32.49%. This contributed to the annual value of $188.3 million for FY2021, which is 20.79% down from last year.
  • Per TherapeuticsMD's latest filing, its Total Debt stood at $188.3 million for FY2021, which was down 20.79% from $237.7 million recorded in FY2020.
  • TherapeuticsMD's 5-year Total Debt high stood at $237.7 million for FY2020, and its period low was $73.4 million during FY2018.
  • For the 3-year period, TherapeuticsMD's Total Debt averaged around $206.9 million, with its median value being $194.6 million (2019).
  • In the last 5 years, TherapeuticsMD's Total Debt surged by 165.24% in 2019 and then decreased by 20.79% in 2021.
  • TherapeuticsMD's Total Debt (Yearly) stood at $73.4 million in 2018, then skyrocketed by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020, then decreased by 20.79% to $188.3 million in 2021.